(Q54458754)

30 May 2018

title

Clinicopathologic characteristics of YES-associated protein 1 overexpression and its relationship to tumor biomarkers in gastric cancer. (English)

1 reference

30 May 2018

0 references

1 reference

J Zhang

1

1 reference

30 May 2018

Y-C Yang

2

1 reference

30 May 2018

J-S Zhu

3

1 reference

30 May 2018

Z Zhou

4

1 reference

30 May 2018

W-X Chen

5

1 reference

30 May 2018

publication date

1 October 2012

1 reference

30 May 2018

International Journal of Immunopathology and Pharmacology

published in

1 reference

30 May 2018

volume

25

1 reference

30 May 2018

issue

4

1 reference

30 May 2018

page(s)

977-987

1 reference

30 May 2018

The Hippo pathway in biological control and cancer development

cites work

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500415

Targeting YAP and Hippo signaling pathway in liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500415

Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500415

Expression of Yes-associated protein in common solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500415

YAP is a candidate oncogene for esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500415

YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500415

Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500415

Loss of Yes-associated protein (YAP) expression is associated with estrogen and progesterone receptors negativity in invasive breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500415

YAP dysregulation by phosphorylation or ΔNp63-mediated gene repression promotes proliferation, survival and migration in head and neck cancer subsets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500415

Yes-associated protein (YAP) functions as a tumor suppressor in breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500415

YAP accelerates Aβ(25-35)-induced apoptosis through upregulation of Bax expression by interaction with p73.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500415

JNK phosphorylates Yes-associated protein (YAP) to regulate apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500415

Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500415

The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500415

Yes-associated protein promotes tumour development in luminal epithelial derived breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500415

Yes-associated protein 1 is widely expressed in human brain tumors and promotes glioblastoma growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500415

Differential expression of Yes-associated protein is correlated with expression of cell cycle markers and pathologic TNM staging in non-small-cell lung carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500415

Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear accumulation associates with poor prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500415

Significance and relationship between Yes-associated protein and survivin expression in gastric carcinoma and precancerous lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500415

EGFR in gastric carcinomas: prognostic significance of protein overexpression and high gene copy number

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500415

Prognostic significance of cyclooxygenase-2, epidermal growth factor receptor 1, and microvascular density in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500415

YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500415

Analysis of EGFR, HER2, and TOP2A gene status and chromosomal polysomy in gastric adenocarcinoma from Chinese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500415

Pharmacodynamic Studies of Gefitinib in Tumor Biopsy Specimens From Patients With Advanced Gastric Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500415

10.1177/039463201202500415

21 January 2018

Identifiers

DOI

1 reference

30 May 2018

1 reference

30 May 2018